Sort
82,697 grants matching “vaccine development”
Tuberculosis Research Unit
$1,037,577W. Henry Boom · Case Western Reserve University · N01 · FY2013 · AI
Mechanism of action and therapeutic utility of stimulatory CpG oligonucleotides
$1,037,336Dennis Klinman · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
MUCOSAL IMMUNITY AND INFECTION
$1,037,312Case Western Reserve University · P01 · FY2004 · AI
Development of NHP Models for Infectious Pathogens of Man
$1,037,303Mario Roederer · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Advancing a Candidate Polyclonal Antibody Therapy for Hantavirus Disease
$1,037,264Jay Williams Hooper · Geneva Foundation · R01 · FY2017 · AI
SBIR: In vivo validation and IND-enabling development of MM004, a bispecific inhaled immunotherapy for RSV and MPV
$1,037,049Richard A Cone · Mucommune, Llc · R44 · FY2024 · AI
Development of IFN-lambda3 for the Prevention and Treatment of Virus Infection
$1,036,895Sergei V Kotenko · Rbhs-New Jersey Medical School · R01 · FY2013 · AI
CENTER FOR AIDS RESEARCH
$1,036,824University Of California San Diego · P30 · FY2000 · AI
Immune responses to HPV infection and HPV vaccination
$1,036,769Mahboobeh Safaeian · Division Of Cancer Epidemiology And Genetics · ZIA · FY2012 · CA
Ontogeny &Maintenance of Virus Specific T Cells
$1,036,550Univ Of Massachusetts Med Sch Worcester · P01 · FY2003 · AI
SBIR: In vivo validation and IND-enabling development of MM004, a bispecific inhaled immunotherapy for RSV and MPV
$1,036,484Richard A Cone · Mucommune, Llc · R44 · FY2023 · AI
St. Jude/Memphis IMPAACT Clinical Trials Unit (Composite)
$1,036,282Patricia Michele Flynn · St. Jude Children'S Research Hospital · UM1 · FY2013 · AI
Accelerating discovery of an efficacious Plasmodium vivax multivalent multi-stage vaccine
$1,036,232John Adams · University Of South Florida · U01 · FY2021 · AI
International Studies Of Acquired Immune Deficiency Syndrome (AIDS)
$1,036,099Thomas Quinn · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Structural Biology Core
$1,036,026Stephen C Harrison · Duke University · U19 · FY2011 · AI
Project 1 - Development of mRNA Immunogens for Protective Antibody Induction
$1,035,959Barton F Haynes · Duke University · U19 · FY2024 · AI
Immunopathogenesis of Acute HIV-1 Infection
$1,035,733University Of Colorado Denver · P01 · FY2003 · AI
Host Immunity Against Bacteria
$1,035,686Sandip Datta · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Pediatric AIDS Clinical Trials Group
$1,035,290St. Jude Children'S Research Hospital · U01 · FY2005 · AI
Development of sG as a human vaccine against Nipah/Hendra
$1,035,051Timothy R Fouts · Profectus Biosciences, Inc. · R01 · FY2015 · AI
Monoclonal Antibody Therapy for West Nile Virus
$1,034,837Michael S. Diamond · Washington University · U01 · FY2009 · AI
Small Molecular Inactivators of HIV
$1,034,506Daniel H Appella · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK
Small Molecular Inactivators of HIV
$1,034,506Daniel H Appella · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK
Development of FISH Molecular Diagnostics to support Clinical Trials at NCI
$1,034,468Liqiang Xi · Division Of Basic Sciences - Nci · ZID · FY2022 · CA
Development of a Preclinical Assay to Predict Efficacy of Ricin Toxin Subunit Vaccines
$1,034,414Nicholas J Mantis · Wadsworth Center · R01 · FY2018 · AI